Skip to content
OpenCapital
Get started

Neuronetics STIM Q4 2025 Annual earnings

Reported March 17, 2026 · Before market open

Revenue$41.8MBeat by $1.1M
EPS-$0.10Beat by $0.02
Revenue estimate$40.7M
EPS estimate-$0.12

Next report

Aug 4, 2026 (In 6 days)
Revenue estimate$40.2M
EPS estimate-$0.11

Financials

Q4 2025

Income statement

See full
Revenue$41.8M+85.7%
Gross profit$21.7M+45.7%
Operating income-$5.0M+56.0%
Net income-$7.2M+43.5%
EPS (diluted)-$0.10+70.6%

Balance sheet

See full
Cash & equivalents$28.1M+52.4%
Total debt$90.3M+9.3%
Total equity$22.4M-19.2%
Total assets$141.6M+0.5%

Cash flow

See full
Operating cash flow-+100%
CapEx$216.0K+143%
Free cash flow-+100%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$94.51M+5.5%
Enterprise value$156.68M+1.9%
P/S0.6×-0.6×

Profitability

See full
Gross margin48.5%-23.8pp
Operating margin-21.1%-7.4pp
Net margin-26.1%-9.3pp
FCF margin-14.7%-5.8pp

Returns & leverage

See full
Return on equity-155.7%+17.8pp
Debt / equity4×+1.1×
Current ratio2×+0.2×

Segments

By product

See full
Clinic Revenue$23.5M+2,013%
Treatment Sessions$12.8M-1.8%
Neuro Star Advanced Therapy System$4.9M+18.0%

By geography

See full
Non Us$1.1M+31.3%

Versus estimates

Revenue

Q1 2026$34.5MBeat by $286.0K
Q4 2025$41.8MBeat by $1.1M
Q3 2025$37.3MMiss by $549.0KQ2 2025$38.1MBeat by $262.0KQ1 2025$32.0MMiss by $4.6MQ4 2024$22.5MMiss by $6.3M

Diluted EPS

Q1 2026-$0.16Beat by $0.01
Q4 2025-$0.10Beat by $0.02
Q3 2025-$0.13Miss by $0.01Q2 2025-$0.15Miss by $0.07Q1 2025-$0.21Miss by $0.08Q4 2024-$0.33Miss by $0.07

Ask the moment Neuronetics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Neuronetics report Q4 2025 earnings?
Neuronetics (STIM) reported Q4 2025 earnings on March 17, 2026 before market open.
What were Neuronetics's Q4 2025 revenue and EPS?
Neuronetics reported revenue of $41.8M and eps of $-0.10 for Q4 2025.
Did Neuronetics beat estimates in Q4 2025?
Revenue beat the consensus estimate of $40.7M by $1.1M. EPS beat the consensus estimate of $-0.12 by $0.02.
How did Neuronetics's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 85.7% from $22.5M a year earlier and eps grew 69.7% from $-0.33.
Where can I find Neuronetics's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-109403) and the 10-K periodic report (0001104659-26-029004) directly on SEC EDGAR. The filing index links above go to sec.gov.